 Objectives: 1 To improve our understanding of the underlying pro-arrhythmic substrate and electrophysiologic mechanisms of VA in NICM, and to develop individualized treatment for VA based on the identified substrate. 2 To improve risk stratification for VA and sudden cardiac death in NICM based on substrate characteristics. 3 to evaluate disease progression in NICM. 